Literature DB >> 23489139

Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease.

Mihai Roca1, Alessia Verduri, Lorenzo Corbetta, Enrico Clini, Leonardo M Fabbri, Bianca Beghé.   

Abstract

Exacerbations of chronic obstructive respiratory disease (ECOPD) are acute events characterized by worsening of the patient's respiratory symptoms, particularly dyspnoea, leading to change in medical treatment and/or hospitalisation. AECOP are considered respiratory diseases, with reference to the respiratory nature of symptoms and to the involvement of airways and lung. Indeed respiratory infections and/or air pollution are the main causes of ECOPD. They cause an acute inflammation of the airways and the lung on top of the chronic inflammation that is associated with COPD. This acute inflammation is responsible of the development of acute respiratory symptoms (in these cases the term ECOPD is appropriate). However, the acute inflammation caused by infections/pollutants is almost associated with systemic inflammation, that may cause acute respiratory symptoms through decompensation of concomitant chronic diseases (eg acute heart failure, thromboembolism, etc) almost invariably associated with COPD. Most concomitant chronic diseases share with COPD not only the underlying chronic inflammation of the target organs (i.e. lungs, myocardium, vessels, adipose tissue), but also clinical manifestations like fatigue and dyspnoea. For this reason, in patients with multi-morbidity (eg COPD with chronic heart failure and hypertension, etc), the exacerbation of respiratory symptoms may be particularly difficult to investigate, as it may be caused by exacerbation of COPD and/or ≥ comorbidity, (e.g. decompensated heart failure, arrhythmias, thromboembolisms) without necessarily involving the airways and lung. In these cases the term ECOPD is inappropriate and misleading.
© 2013 The Authors. European Journal of Clinical Investigation © 2013 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Year:  2013        PMID: 23489139     DOI: 10.1111/eci.12064

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  12 in total

Review 1.  Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications.

Authors:  Hammad Qureshi; Amir Sharafkhaneh; Nicola A Hanania
Journal:  Ther Adv Chronic Dis       Date:  2014-09       Impact factor: 5.091

Review 2.  Acute oxygen therapy: a review of prescribing and delivery practices.

Authors:  Joyce L Cousins; Peter A B Wark; Vanessa M McDonald
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-05-24

3.  Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm.

Authors:  Kirill A Zykov; Svetlana I Ovcharenko
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-11

Review 4.  Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients.

Authors:  Zaurbek Aisanov; Nikolai Khaltaev
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

5.  Ability of the LACE index to predict 30-day hospital readmissions in patients with community-acquired pneumonia.

Authors:  Claudia C Dobler; Maryam Hakim; Sidhartha Singh; Matthew Jennings; Grant Waterer; Frances L Garden
Journal:  ERJ Open Res       Date:  2020-07-20

6.  Effect of Liuzijue Qigong on patients with chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis.

Authors:  Yu Guo; Mingmin Xu; Meiqi Ji; Jialei Zhang; Qingchuan Hu; Zeren Wei; Jian Yan; Yue Chen; Jiaxuan Lyu; Xiaoqian Shao; Ying Wang; Jiamei Guo; Yulong Wei
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  Chronic obstructive pulmonary disease exacerbations and progression in relation to ambient air pollutants exposure.

Authors:  Miglena Doneva; Guenka Petrova; Daniela Petrova; Maria Kamusheva; Valentina Petkova; Konstantin Tachkov; Ventsislava Pencheva; Ognyan Georgiev
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

8.  The effects of a physical activity counseling program after an exacerbation in patients with Chronic Obstructive Pulmonary Disease: a randomized controlled pilot study.

Authors:  Miek Hornikx; Heleen Demeyer; Carlos Augusto Camillo; Wim Janssens; Thierry Troosters
Journal:  BMC Pulm Med       Date:  2015-11-04       Impact factor: 3.317

9.  Exposure to atmospheric particulate matter enhances Th17 polarization through the aryl hydrocarbon receptor.

Authors:  Michael van Voorhis; Samantha Knopp; Walker Julliard; John H Fechner; Xiaoji Zhang; James J Schauer; Joshua D Mezrich
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

10.  Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD.

Authors:  Sara Roversi; Roberto Tonelli; Bianca Beghè; Federico Banchelli; Roberto D'Amico; Mario Malerba; Leonardo M Fabbri; Enrico M Clini
Journal:  ERJ Open Res       Date:  2018-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.